Defining response to anti-VEGF therapies in neovascular AMD.

MLA

Amoaku, W. M., et al. “Defining Response to Anti-VEGF Therapies in Neovascular AMD.” Eye (London, England), vol. 29, no. 10, Oct. 2015, pp. 1397–98. EBSCOhost, https://doi.org/10.1038/eye.2015.159.

APA

Amoaku, W. M., Chakravarthy, U., Gale, R., Gavin, M., Ghanchi, F., Gibson, J., Harding, S., Johnston, R. L., Kelly, S. P., Lotery, A., Mahmood, S., Menon, G., Sivaprasad, S., Talks, J., Tufail, A., & Yang, Y. (2015). Defining response to anti-VEGF therapies in neovascular AMD. Eye (London, England), 29(10), 1397–1398. https://doi.org/10.1038/eye.2015.159

Chicago

Amoaku, W M, U Chakravarthy, R Gale, M Gavin, F Ghanchi, J Gibson, S Harding, et al. 2015. “Defining Response to Anti-VEGF Therapies in Neovascular AMD.” Eye (London, England) 29 (10): 1397–98. doi:10.1038/eye.2015.159.